TCHBF (Tecan Group AG) Research & Development: $85 Mil (TTM As of Dec. 2025)


TCHBF Tecan Group AG TCHBF
76 GF Score
Price $198.00
GF Value $273.48
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Tecan Group AG Research & Development?

Tecan Group AG TCHBF 76 Research & Development is $85 Mil as of Dec. 2025. GuruFocus rates TCHBF with a GF Score™ of 76/100 and a GF Value™ of $273.48 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Tecan Group AG's Research & Development for the six months ended in Dec. 2025 was $42 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $85 Mil.

Tecan Group AG  (OTCPK:TCHBF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Tecan Group AG Research & Development Related Terms

Tecan Group AG Research & Development Historical Data

* Premium members only.

The historical data trend for Tecan Group AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tecan Group AG Research & Development Chart

Tecan Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.03 83.61 80.64 76.70 86.06

Tecan Group AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.20 36.64 39.97 43.36 41.82
TCHBF
76GF Score
Tecan Group AG TCHBF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tecan Group AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $85 Mil mean?
Tecan Group AG (TCHBF) has a Research & Development of $85 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Tecan Group AG and its competitors.
Is Tecan Group AG's Research & Development too high?
Tecan Group AG's current Research & Development is $85 Mil. Overall, Tecan Group AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's Research & Development compare to ISRG and BDX?
Tecan Group AG's Research & Development of $85 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Tecan Group AG and its competitors. Tecan Group AG's current Research & Development is $85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Based on GuruFocus' analysis, Tecan Group AG (TCHBF) is currently considered Modestly Undervalued. The stock's GF Value™ is $273.48, compared to a current price of $198.00 — trading 27.6% below its estimated fair value. The current Research & Development is $85 Mil. Tecan Group AG's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Tecan Group AG (TCHBF), the current Research & Development is $85 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tecan Group AG (TCHBF) Overvalued in 2026?

Based on GuruFocus' analysis, Tecan Group AG stock appears to be undervalued. The current stock price of $198.00 is trading 27.6% below its estimated GF Value™ of $273.48. GuruFocus considers Tecan Group AG to be Modestly Undervalued.

Key valuation signals for TCHBF:

  • Research & Development: $85 Mil
  • GF Value™: $273.48 vs. price of $198.00 (27.6% below fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the TCHBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tecan Group AG Business Description

Address Seestrasse 103, Mannedorf, CHE, 8708
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
76GF Score

Get the complete analysis for TCHBF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$198.00
Price
$273.48
GF Value